Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease

Proton pump inhibitors (PPIs) have been the first line treatment for gastroesophageal reflux disease (GERD). The aim of this study was to evaluate the efficacy of vonoprazan (VPZ), a potassium-competitive acid blocker for reflux esophagitis (RE), nonerosive reflux disease (NERD), and PPI-resistant G...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicine (Baltimore)
Prif Awduron: Gotoh, Yasuhiko, Ishibashi, Emiko, Honda, Shunichiro, Nakaya, Tomohisa, Noguchi, Chishio, Kagawa, Koichi, Murakami, Kazunari
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wolters Kluwer Health 2020
Pynciau:
4500
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440130/
https://ncbi.nlm.nih.gov/pubmed/32176102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019520
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg